Alpha 2.0
Login Register
» Authors » Fahimeh Varzideh

Fahimeh Varzideh

Explore the profile of Fahimeh Varzideh including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 67
Citations 848
Followers 0
Related Specialties
Cardiology & Vascular Diseases
Endocrinology
Pharmacology
Top 10 Co-Authors
Gaetano Santulli
Urna Kansakar
Pasquale Mone
Stanislovas S Jankauskas
Jessica Gambardella
Angela Lombardi
Roberta Avvisato
Imma Forzano
Tullio Tesorio
Antonella Pansini
Published In
Cardiovasc Diabetol
Hypertension
J Pharmacol Exp Ther
Vascul Pharmacol
Int J Mol Sci
Affiliations
Soon will be listed here.
Recent Articles
1.
Integrating Proteomics and Mendelian Randomization to Identify New Therapeutic Targets
Santulli G, Varzideh F, Kansakar U, Jankauskas S, Wilson S, Mone P
Am J Hypertens . 2025 Mar; PMID: 40083258
No abstract available.
2.
Functional role of circular RNA XYLT1 in vascular remodeling and oxidative stress in aging
Varzideh F, Mone P, Kansakar U, Santulli G
Exp Gerontol . 2025 Mar; :112728. PMID: 40057052
No abstract available.
3.
Low LDL-cholesterol drives the risk of bleeding in patients treated with aspirin: A 15-year study in a real-world large population
Trimarco V, Izzo R, Pacella D, Varzideh F, Manzi M, Gallo P, et al.
Pharmacol Res . 2025 Mar; :107688. PMID: 40054543
We aimed to investigate the link between LDL cholesterol (LDL-C) levels and hemorrhage risk over an extended period, both in subjects taking aspirin and in individuals not receiving any antiplatelet...
4.
Macrophages Regulate Inflammatory Vascular Remodeling in Pulmonary Hypertension
Varzideh F, Forzano I, Farroni E, Mone P, Kansakar U, Santulli G
Hypertension . 2025 Feb; 82(3):460-462. PMID: 39970256
No abstract available.
5.
Elamipretide: A Review of Its Structure, Mechanism of Action, and Therapeutic Potential
Tung C, Varzideh F, Farroni E, Mone P, Kansakar U, Jankauskas S, et al.
Int J Mol Sci . 2025 Feb; 26(3). PMID: 39940712
Mitochondria serve an essential metabolic and energetic role in cellular activity, and their dysfunction has been implicated in a wide range of disorders, including cardiovascular conditions, neurodegenerative disorders, and metabolic...
6.
The selective sorting of miR-4432 into endothelial extracellular vesicles is controlled by a specific RNA binding protein: New Insights in the pathophysiology of venous malformations
Jankauskas S, Varzideh F, Farroni E, Mone P, Kansakar U, Santulli G
Br J Dermatol . 2025 Jan; PMID: 39873370
No abstract available.
7.
TMAO accelerates cellular aging by disrupting endoplasmic reticulum integrity and mitochondrial unfolded protein response
Varzideh F, Farroni E, Kaunsakar U, Eiwaz M, Jankauskas S, Santulli G
Cell Mol Life Sci . 2025 Jan; 82(1):53. PMID: 39833549
No abstract available.
8.
Targeting miR-199a reduces fibrosis in hypertrophic cardiomyopathy
Jankauskas S, Varzideh F, Kansakar U, Santulli G
J Mol Cell Cardiol Plus . 2025 Jan; 7():100057. PMID: 39802443
No abstract available.
9.
Myosin activator omecamtiv mecarbil exhibits divergent inotropic and lusitropic effects in cardiac slices from patients with heart failure
Varzideh F, Mone P, Salemme L, Forzano I, Cioppa A, Tesorio T, et al.
J Mol Cell Cardiol Plus . 2025 Jan; 5():100041. PMID: 39802175
No abstract available.
10.
Circulating levels of cadherins are associated with atherosclerosis and cardiovascular outcomes
Santulli G, Varzideh F, Qin Y, Wang B, Kansakar U, Jankauskas S
J Mol Cell Cardiol Plus . 2025 Jan; 10():100092. PMID: 39801807
No abstract available.